SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-043893
Filing Date
2013-05-22
Accepted
2013-05-22 16:36:43
Documents
4
Period of Report
2013-05-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-12849_48k.htm 8-K 28501
2 UNDERWRITING AGREEMENT, DATED MAY 21,2013 a13-12849_4ex1d1.htm EX-1.1 261198
3 OPINION OF JENNER & BLOCK LLP a13-12849_4ex5d1.htm EX-5.1 13890
4 GRAPHIC g128494kgi001.jpg GRAPHIC 1798
  Complete submission text file 0001104659-13-043893.txt   307318
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23272 | Film No.: 13865250
SIC: 2836 Biological Products, (No Diagnostic Substances)